ClinicalTrials.gg
Drug

N-Methyl-3,4-methylenedioxyamphetamine clinical trials

Also written MDMA.

Includes 2 studies of Midomafetamine hydrochloride.

studies test it
91
open now
23
in phase 3
6
first study started
2001

How each study uses N-Methyl-3,4-methylenedioxyamphetamine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the N-Methyl-3,4-methylenedioxyamphetamine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Midomafetamine HCl
19
MDMA HCl
10
3,4-methylenedioxymethamphetamine (MDMA)
3
3,4 Methylenedioxymethamphetamine
2
3,4-Methyl enedioxy methamphetamine
2

Other names

MDMA
75
3,4-methylenedioxymethamphetamine
48
midomafetamine
26
Ecstasy
9
methylenedioxymethamphetamine
1
MDMA 40mg
1
MDMA 80mg
1
MDMA 120mg
1

Studies by the year they started

91 studies that test it; most in 2025 (12)

Studies that test N-Methyl-3,4-methylenedioxyamphetamine, by start year
YearStudies
20011
20031
20042
20061
20071
20093
20104
20114
20121
20135
20143
20151
20162
20173
20184
20192
20202
20217
20227
20238
20247
202512
202610

By phase

A phase 1/2 study counts in both.

Early Phase 1
10
Phase 1
31
Phase 2
40
Phase 3
6
No phase
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 29 · Other 62

Lykos Therapeutics (24) · University Hospital, Basel, Switzerland (19) · University of Chicago (7) · Resilient Pharmaceuticals (2) · Emory University (2) · Yale University (2) · Johns Hopkins University (2) · Sunstone Medical (2)

Often tested with

Tested in the same studies.

Psilocybin (4) · Methylphenidate (4) · Lysergic Acid Diethylamide (3) · Methamphetamine (2) · Bean (1) · Tenamfetamine (1) · Carvedilol (1) · Doxazosin (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 11, 1 in phase 3

Studies that test N-Methyl-3,4-methylenedioxyamphetamine, phase 3 first.

Studies

Open first, then newest update. How each study uses N-Methyl-3,4-methylenedioxyamphetamine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 91

See all 91 studies that test N-Methyl-3,4-methylenedioxyamphetamine →

As the comparator · 4 — what is tested is compared with N-Methyl-3,4-methylenedioxyamphetamine

Codes

What other systems call N-Methyl-3,4-methylenedioxyamphetamine · ClinicalTrials.gg INT008652

  • MeSH (NLM) D018817N-Methyl-3,4-methylenedioxyamphetamineConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) KE1SEN21RMMIDOMAFETAMINEConfirmed FDA, NLM

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.